Ȩ Ä«Å×°í¸® ¸ÂÃãÇü½ÃÀåÁ¶»ç ±¹Á¦ÄÁÆÛ·±½º ±Û·Î¹ú ÆÄÆ®³Ê ¸ÞÀϸµ ¼­ºñ½º ȸ»ç¼Ò°³È¸»ç¼Ò°³ Contact Us
English Japaness Chinese
Home > ½ÃÀ庸°í¼­ > ÆÄ¸Ó½´Æ¼Äà > Á¦³×¸¯ ÀǾàǰ > ¹Ì±¹ ¹ÙÀÌ¿À½Ã¹Ð·¯ ½ÃÀå¿¡ ´ëÇÑ Àü¹®ÀÇ ÀÇ°ß : Åä·Ð
Ä«Å×°í¸®
ÆÄ¸Ó½´Æ¼Äà (4931)
°¨¿°Áúȯ (349)
°ñÁúȯ Ä¡·á (38)
´ç´¢º´ (194)
¹é½Å (181)
ºñ¸¸Ä¡·á/´ÙÀÌ¾îÆ® (44)
ºñó¹æ ÀǾàǰ (152)
¼öÀÇÇÐ (17)
½Å°æÁúȯ (174)
½Å¾à°³¹ß (1529)
¾ÏÄ¡·á (941)
¾à¹°Àü´Þ (185)
ÀǾàǰ ±ÔÁ¦È¯°æ (127)
Á¤½ÅÁúȯ (86)
Á¦³×¸¯ ÀǾàǰ (128)
Á¦¾àȸ»çºÐ¼® (523)
󹿾à (165)
½ÃÀ庸°í¼­

¹Ì±¹ ¹ÙÀÌ¿À½Ã¹Ð·¯ ½ÃÀå¿¡ ´ëÇÑ Àü¹®ÀÇ ÀÇ°ß : Åä·Ð

Specialty Physicians Discuss their Opinions of the United States Biosimilars Market

¸®¼­Ä¡»ç Frost & Sullivan
¹ßÇàÀÏ 2011³â 12¿ù »óǰÄÚµå 228271
ÆäÀÌÁö Á¤º¸ 74 Pages
°¡°Ý
US $ 10,000 £Ü 11,915,000 Web Access (Regional License)
US $ 10,500 £Ü 12,510,700 Web Access (Regional License) & Hard Copy


Frost & Sullivan ¿¡¼­ 2011³â 12¿ù ¿¡ ¹ßÇàÇÑ ¡¸¹Ì±¹ ¹ÙÀÌ¿À½Ã¹Ð·¯ ½ÃÀå¿¡ ´ëÇÑ Àü¹®ÀÇ ÀÇ°ß : Åä·Ð¡¹ º¸°í¼­´Â 74 Pages·Î ±¸¼ºµÇ¾î, US $10,000 ºÎÅÍ ±¸¸Å °¡´ÉÇÕ´Ï´Ù.

Çѱ۸ñÂ÷

¹Ì±¹ Àü¹®ÀÇÀÇ ÆÐ³Î Åä·Ð ³»¿ëÀ» ¹ÙÅÁÀ¸·Î, °ð ¹Ì±¹ ½ÃÀå¿¡ µîÀåÇÏ´Â(±×¸®°í ±×µéÀÌ ÃÖÃÊ °í°´ÀÌ µÈ´Ù) ¹ÙÀÌ¿À½Ã¹Ð·¯ Á¦Ç°(Biosimilars)¿¡ °üÇÑ »ý°¢°ú ±â´ë, ºÒ¾È µî¿¡ ´ëÇÑ ºÐ¼® °á°ú¸¦ ÀüÇØµå¸³´Ï´Ù.

1. °³¿ä

2. ¼­·Ð

3. ÀÇ»çÀÇ Ã³¹æ Çൿ

4. ¼ÒºñÀÚÀÇ ±¸¸Å Çൿ

5. ±ÔÁ¦ ȯ°æ

6. ¹ÙÀÌ¿À½Ã¹Ð·¯ Á¦Á¶¾÷ü

7. About Frost & Sullivan

KSM
Back to Top